UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Linc00941 fuels ribogenesis and protein synthesis by supporting robust cMYC translation in malignant pleural mesothelioma

Cancer letters, 2024-06, Vol.592, p.216950, Article 216950

2024

Volltextzugriff (PDF)

Molecular and Immunohistochemical Testing in Mesothelioma and Other Mesothelial Lesions

Archives of pathology & laboratory medicine (1976), 2024-05, Vol.148 (5), p.e77-e89

2024

Volltextzugriff (PDF)

Mesothelioma-Associated Fibroblasts Modulate the Response of Mesothelioma Patient-Derived Organoids to Chemotherapy via Interleukin-6

International journal of molecular sciences, 2024-05, Vol.25 (10), p.5355

2024

Volltextzugriff (PDF)

L1CAM expression in cystic mesothelial lesions: a comparison with adenomatoid tumours, well‐differentiated papillary mesothelial tumours and malignant mesotheliomas

Histopathology, 2021-08, Vol.79 (2), p.272-274

2021

Volltextzugriff (PDF)

Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin

Journal of experimental & clinical cancer research, 2023-01, Vol.42 (1), p.27-27, Article 27

2023

Volltextzugriff (PDF)

Pleural mesothelioma from fluoro-edenite exposure: PACAP and PAC1 receptor. A preliminary report

European journal of histochemistry, 2024-05, Vol.68 (2)

2024

Volltextzugriff (PDF)

Can novel adipokines, asprosin and meteorin-like, be biomarkers for malignant mesothelioma?

Biotechnic & histochemistry, 2020-04, Vol.95 (3), p.171-175

2020

Volltextzugriff (PDF)

Expression and prognostic significance of KAP1 gene in malignant pleural mesothelioma

Zhonghua laodong weisheng zhiyebing zazhi, 2024-04, Vol.42 (4), p.258

2024

Volltextzugriff (PDF)

The role of 18F-FDG-PET/ceCT in peritoneal mesothelioma

Nuclear medicine communications, 2017-04, Vol.38 (4), p.312-318

2017

Volltextzugriff (PDF)

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group

Archives of pathology & laboratory medicine (1976), 2018-01, Vol.142 (1), p.89-108

2018

Volltextzugriff (PDF)

Analysis of expression of programmed cell death 1 ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM)

PloS one, 2015-03, Vol.10 (3), p.e0121071-e0121071

2015

Volltextzugriff (PDF)

Exploiting the folate receptor α in oncology

Nature reviews. Clinical oncology, 2020-06, Vol.17 (6), p.349-359

2020

Volltextzugriff (PDF)

Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma

Journal of thoracic oncology, 2017-09, Vol.12 (9), p.1421-1433

2017

Volltextzugriff (PDF)

Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays

Human pathology, 2019-05, Vol.87, p.11-17

2019

Volltextzugriff (PDF)

Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma

Modern pathology, 2022-10, Vol.35 (10), p.1383-1397

2022

Volltextzugriff (PDF)

A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis

Lung cancer (Amsterdam, Netherlands), 2018-11, Vol.125, p.198-204

2018

Volltextzugriff (PDF)

The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma

Modern pathology, 2016-01, Vol.29 (1), p.14-24

2016

Volltextzugriff (PDF)

Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia

Redox biology, 2019-09, Vol.26, p.101297, Article 101297

2019

Volltextzugriff (PDF)

Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry

Lung cancer (Amsterdam, Netherlands), 2017-02, Vol.104, p.98-105

2017

Volltextzugriff (PDF)

The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma

Journal of thoracic oncology, 2017-05, Vol.12 (5), p.850-859

2017

Volltextzugriff (PDF)

Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis

Cancer letters, 2017-01, Vol.385, p.215-224

2017

Volltextzugriff (PDF)

Utility of Methylthioadenosine Phosphorylase Compared With BAP1 Immunohistochemistry, and CDKN2A and NF2 Fluorescence In Situ Hybridization in Separating Reactive Mesothelial Proliferations From Epithelioid Malignant Mesotheliomas

Archives of pathology & laboratory medicine (1976), 2018-12, Vol.142 (12), p.1549-1553

2018

Volltextzugriff (PDF)

Exosomal transfer of miR-126 promotes the anti-tumour response in malignant mesothelioma: Role of miR-126 in cancer-stroma communication

Cancer letters, 2019-10, Vol.463, p.27-36

2019

Volltextzugriff (PDF)

BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma

Human pathology, 2015-11, Vol.46 (11), p.1670-1678

2015

Volltextzugriff (PDF)

1 – 25 von 2.236

Suche als RSS-Feed

Aktive Filter

ThemaAnimals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.045)
Mit Volltextzugriff
(1.929)

Publikationsform

Sprache

10 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(2.168)
EZB Electronic Journals Library
(1.256)
IngentaConnect
(1.036)
Journals@Ovid
(921)
IngentaConnect Journals
(586)
Publisher website
(446)
Wiley-Blackwell Journals
(366)
ScienceDirect
(356)
Wiley Online Library
(294)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(251)
Springer journals
(229)
Nature_系列刊
(142)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(128)
Taylor & Francis Journals Auto-Holdings Collection
(88)
Nexis Uni
(74)
Taylor & Francis
(74)
Taylor & Francis Online
(71)
Oxford journals
(66)
Oxford Journals 2020 Medicine
(59)
BMJ_英国医学会期刊
(48)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(64)
Lung Cancer
(54)
Journal Of Thoracic Oncology
(50)
Histopathology
(48)
Human Pathology
(43)
International Journal Of Molecular Sciences
(42)
Anticancer Research
(40)
Cancer Research
(38)
Diagnostic Cytopathology
(37)
Modern Pathology
(36)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Linc00941 fuels ribogenesis and protein synthesis by supporting robust cMYC translation in malignant pleural mesothelioma

Molecular and Immunohistochemical Testing in Mesothelioma and Other Mesothelial Lesions

Mesothelioma-Associated Fibroblasts Modulate the Response of Mesothelioma Patient-Derived Organoids to Chemotherapy via Interleukin-6

L1CAM expression in cystic mesothelial lesions: a comparison with adenomatoid tumours, well‐differentiated papillary mesothelial tumours and malignant mesotheliomas

Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin

Pleural mesothelioma from fluoro-edenite exposure: PACAP and PAC1 receptor. A preliminary report

Can novel adipokines, asprosin and meteorin-like, be biomarkers for malignant mesothelioma?

Expression and prognostic significance of KAP1 gene in malignant pleural mesothelioma

Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations

The role of 18F-FDG-PET/ceCT in peritoneal mesothelioma

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group

Analysis of expression of programmed cell death 1 ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM)

Exploiting the folate receptor α in oncology

Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma

Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays

Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma

A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis

The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma

Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia

Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry

The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma

Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis

Utility of Methylthioadenosine Phosphorylase Compared With BAP1 Immunohistochemistry, and CDKN2A and NF2 Fluorescence In Situ Hybridization in Separating Reactive Mesothelial Proliferations From Epithelioid Malignant Mesotheliomas

Exosomal transfer of miR-126 promotes the anti-tumour response in malignant mesothelioma: Role of miR-126 in cancer-stroma communication

BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma

Aktive Filter

Suchergebnisse filtern